financetom
Business
financetom
/
Business
/
CT REIT Credit Ratings Confirmed at DBRS
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CT REIT Credit Ratings Confirmed at DBRS
May 10, 2024 11:24 AM

02:04 PM EDT, 05/10/2024 (MT Newswires) -- Morningstar DBRS on Thursday confirmed CT Real Estate Investment Trust's (CRT-UN.TO) senior unsecured debentures credit rating and CT REIT Limited Partnership's issuer rating at BBB.

Both trends are stable.

The credit ratings reflect CT REIT's risk profile and the credit ratings are aligned with those of Canadian Tire (CTC.TO), mainly because CTC effectively controls CT REIT through its majority ownership and is the most substantial tenant of CT REIT, among other reasons.

Price: 13.89, Change: +0.01, Percent Change: +0.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Zeekr Accused of Inflating Sales by Pre-Insuring Unsold Vehicles in China
Market Chatter: Zeekr Accused of Inflating Sales by Pre-Insuring Unsold Vehicles in China
Jul 21, 2025
07:31 AM EDT, 07/21/2025 (MT Newswires) -- Zeekr Intelligent Technology ( ZK ) allegedly inflated its sales figures by insuring unsold vehicles to meet monthly and quarterly sales targets, Reuters reported Monday, citing documents and interviews with dealers and customers. According to the report, Zeekr, through its primary distributor, state-owned Xiamen C&D Automobile, pre-registered vehicles as sold by insuring them,...
Oruka Therapeutics Secures FDA Clearance for Phase 2a Trial of ORKA-001 in Psoriasis
Oruka Therapeutics Secures FDA Clearance for Phase 2a Trial of ORKA-001 in Psoriasis
Jul 21, 2025
07:32 AM EDT, 07/21/2025 (MT Newswires) -- Oruka Therapeutics ( ORKA ) said Monday the US Food and Drug Administration has cleared its investigational new drug application to start the phase 2a trial of ORKA-001 intended for moderate to severe psoriasis. The company said it aims to enroll about 80 patients under the trial, with a primary endpoint of PASI...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
S&P Dow Jones Indices to Acquire ARC Research for Private Wealth Data Expansion
S&P Dow Jones Indices to Acquire ARC Research for Private Wealth Data Expansion
Jul 21, 2025
07:29 AM EDT, 07/21/2025 (MT Newswires) -- S&P Global's ( SPGI ) division S&P Dow Jones Indices said Monday it has signed a definitive agreement to acquire ARC Research, a subsidiary of ARC Group, to expand its investment performance data and benchmarking capabilities in the private wealth market. ARC Research holds a proprietary dataset comprising over 500,000 private client portfolios...
Copyright 2023-2026 - www.financetom.com All Rights Reserved